Listed drug companies to spend 70% of net incomes for R&D.
The KPMA reported the 2005 business performances by 37 listed drug companies as 5,717,200 million won of the total sales, 438,500 million won of net incomes (7.67% of sales) and 312,700 million won...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
